Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Vaccines

Free Subscription 30.03.2026 1 BMJ 4 J Infect Dis 1 J Virol 1 MMWR Morb Mortal Wkly Rep 1 N Engl J Med 1 Nat Med 1 Pediatr Infect Dis J 1 PLoS One 1 Proc Natl Acad Sci U S A 15 Vaccine 1 Virology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMJ

1. WISE J
   Covid vaccines are not linked to sudden death in healthy younger adults, study finds.
   BMJ. 2026;392:s589.
   PubMed        
   
   

   
   J Infect Dis

2. CHEN WH, Beckett CG, Al-Ibrahim M, Datar R, et al
   Safety and Immunogenicity of a Trivalent Salmonella Conjugate Vaccine to S. Typhi, S. Typhimurium, and S. Enteritidis.
   J Infect Dis. 2026 Mar 26:jiag156. doi: 10.1093.
   PubMed         Abstract available
   
   
3. KACHIKIS A, Frivold C, Pike M, Reed JC, et al
   Comparison of Respiratory Syncytial Virus (RSV)-Specific Antibody Durability in Pregnant/Postpartum Individuals and Older Adults After RSV Vaccination.
   J Infect Dis. 2026 Mar 26:jiag111. doi: 10.1093.
   PubMed         Abstract available
   
   
4. JIHAD T, Chi XS, He Z, Lee K, et al
   Establishment of a Neonatal Natural Transmission Model for CMV Vaccine Development.
   J Infect Dis. 2026 Mar 23:jiag170. doi: 10.1093.
   PubMed         Abstract available
   
   
5. PERSSON C
   Comment on: "Mucosal and Systemic Antibody Responses After Boosting With a Bivalent Messenger RNA Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine".
   J Infect Dis. 2026 Mar 20:jiag180. doi: 10.1093.
   PubMed        
   
   

   
   J Virol

6. WANG J, Chang J, Jiang Z, Deng H, et al
   An oral rotavirus-vectored vaccine confers protection against Clostridium perfringens and rotavirus.
   J Virol. 2026 Mar 26:e0017826. doi: 10.1128/jvi.00178.
   PubMed         Abstract available
   
   

   
   MMWR Morb Mortal Wkly Rep

7. HILL HA, Yankey D, Elam-Evans LD, Mu Y, et al
   Vaccination Coverage by Age 24 Months Among Children Born in 2021 and 2022 - National Immunization Survey-Child, United States, 2022-2024.
   MMWR Morb Mortal Wkly Rep. 2026;75:146-155.
   PubMed         Abstract available
   
   

   
   N Engl J Med

8. OPEL DJ, O'Leary ST
   Communicating about Vaccines in a Politically Contentious Climate.
   N Engl J Med. 2026;394:1145-1147.
   PubMed        
   
   

   
   Nat Med

9. HAANEN JB, Schumacher TNM, Kagan JC, Fritsch EF, et al
   Publisher Correction: Clinical development of cancer vaccines.
   Nat Med. 2026 Mar 26. doi: 10.1038/s41591-026-04361.
   PubMed        
   
   

   
   Pediatr Infect Dis J

10. DE BOCK M, Marbaix S, Goovaerts H, Debieve F, et al
    Health and Economic Impact of Seasonal Maternal Vaccination With Bivalent Respiratory Syncytial Virus Prefusion F Vaccine in Belgium.
    Pediatr Infect Dis J. 2026 Apr 7. doi: 10.1097/INF.0000000000005226.
    PubMed         Abstract available
    
    

    
    PLoS One

11. YAN K, Yang G, Yan L, Wu L, et al
    Global trends and forecasts of cervical cancer and a real-world safety assessment of human papillomavirus vaccines in women: A systematic analysis of the Global Burden of Disease study 2021 and the Vaccine Adverse Event Reporting System database.
    PLoS One. 2026;21:e0345286.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

12. 
    Correction for Te et al., Broad beta-CoV immunity and transmission blockade by a single-dose live-attenuated vaccine with atypical codon usage.
    Proc Natl Acad Sci U S A. 2026;123:e2607878123.
    PubMed        
    
    

    
    Vaccine

13. JAMES E, Christie S, Boye B, Githieya D, et al
    How to leverage social media to build confidence in COVID-19 vaccines: findings and lessons learned from nationwide campaigns in four countries.
    Vaccine. 2026;79:128475.
    PubMed         Abstract available
    
    
14. FRAWLEY JE, Hutchens J, Wiley K, Mahimbo A, et al
    Uptake of Commonwealth funded influenza vaccines for Australian children aged 6-months to <5 years during the COVID-19 pandemic.
    Vaccine. 2026;79:128514.
    PubMed         Abstract available
    
    
15. OOI JSG, Hamis NZ, Tan HC, Yee JX, et al
    Neutralizing antibody titers do not predict T cell response to live-attenuated orthoflaviviral vaccination in humans.
    Vaccine. 2026;79:128510.
    PubMed         Abstract available
    
    
16. ZHONG L, Tao L, Zhai Z, Liao L, et al
    The stability landscape of mRNA vaccines: challenges and mitigation strategies.
    Vaccine. 2026;79:128515.
    PubMed         Abstract available
    
    
17. VARGAS-ZAMBRANO JC, Arnaud M, Antunes A, Karzazi K, et al
    Evaluating pertussis vaccine effectiveness in children under 5 years of age born in France between 2013 and 2019.
    Vaccine. 2026;79:128472.
    PubMed         Abstract available
    
    
18. SIMON R, Arrogante A, Nogales-Merida S, Diaz-Rosales P, et al
    DNA vaccination against viral hemorrhagic septicemia virus (VHSV) affects the capacity of kidney leukocytes to respond to a posterior viral encounter.
    Vaccine. 2026;79:128512.
    PubMed         Abstract available
    
    
19. MALDEN DE, Ackerson BK, Gee J, Peryer MA, et al
    Self-reported reactogenicity of RSV vaccines among older adults: a post-licensure study within a large integrated healthcare system in Southern California.
    Vaccine. 2026;79:128493.
    PubMed         Abstract available
    
    
20. FANTIN R, Das S, Loria V, Calderon A, et al
    Hybrid immunity provides stronger protection against SARS-CoV-2 infection than vaccination alone: Evidence from a population-based active monitoring study.
    Vaccine. 2026;79:128506.
    PubMed         Abstract available
    
    
21. DENG L, Barton B, Choi P, Clarke L, et al
    Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia.
    Vaccine. 2026;79:128501.
    PubMed         Abstract available
    
    
22. HUANG A, Li J, Tang L, Xu X, et al
    Cost-effectiveness of hepatitis A vaccination for adults in China: A decision tree Markov model study.
    Vaccine. 2026;79:128509.
    PubMed         Abstract available
    
    
23. VONDELING GT, Croda J, Jelinek T, Kassianos G, et al
    Post-marketing safety evaluation of the live-attenuated chikungunya vaccine (IXCHIQ).
    Vaccine. 2026;79:128491.
    PubMed         Abstract available
    
    
24. BRIGGS K, Gingerich MC, Gingerich A, Johnson SK, et al
    Intranasal PIV5-vectored SARS-COV-2 KP.2 vaccine protects against homologous and heterologous challenge in mice and hamsters.
    Vaccine. 2026;79:128490.
    PubMed         Abstract available
    
    
25. QUACH HQ, Ratishvili T, Haralambieva IH, Ovsyannikova IG, et al
    Sex-based differences in mumps immunity after a third dose of measles-mumps-rubella vaccine.
    Vaccine. 2026;79:128480.
    PubMed         Abstract available
    
    
26. ROSSO A, Riccio M, Renzi E, Patania F, et al
    The role of school-based health education in promoting childhood and adolescent vaccination: A systematic review and Meta-analysis.
    Vaccine. 2026;79:128479.
    PubMed         Abstract available
    
    
27. SILVA LL, Lopes VDS, da Silva DCB, Nemer CRB, et al
    Global overview of vaccine trust: Evidence from a scoping review.
    Vaccine. 2026;79:128482.
    PubMed         Abstract available
    
    

    
    Virology

28. MORALES RUIZ S, Wang Z, Miura T, Shida H, et al
    Potent protective ability of vaccinia virus LC16 strains lacking the B5R gene.
    Virology. 2026;619:110888.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum